BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 23739867)

  • 1. Expression profiles of vault components MVP, TEP1 and vPARP and their correlation to other multidrug resistance proteins in ovarian cancer.
    Szaflarski W; Sujka-Kordowska P; Pula B; Jaszczyńska-Nowinka K; Andrzejewska M; Zawierucha P; Dziegiel P; Nowicki M; Ivanov P; Zabel M
    Int J Oncol; 2013 Aug; 43(2):513-20. PubMed ID: 23739867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of MVP and VPARP promoters indicates a role for chromatin remodeling in the regulation of MVP.
    Emre N; Raval-Fernandes S; Kickhoefer VA; Rome LH
    Biochim Biophys Acta; 2004 Apr; 1678(1):33-46. PubMed ID: 15093136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of vaults may be necessary but not sufficient for multidrug resistance.
    Siva AC; Raval-Fernandes S; Stephen AG; LaFemina MJ; Scheper RJ; Kickhoefer VA; Rome LH
    Int J Cancer; 2001 Apr; 92(2):195-202. PubMed ID: 11291045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryoelectron microscopy imaging of recombinant and tissue derived vaults: localization of the MVP N termini and VPARP.
    Mikyas Y; Makabi M; Raval-Fernandes S; Harrington L; Kickhoefer VA; Rome LH; Stewart PL
    J Mol Biol; 2004 Nov; 344(1):91-105. PubMed ID: 15504404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The roles of four multi-drug resistance proteins in hepatocellular carcinoma multidrug resistance.
    Li G; Chen X; Wang Q; Xu Z; Zhang W; Ye L
    J Huazhong Univ Sci Technolog Med Sci; 2007 Apr; 27(2):173-5. PubMed ID: 17497289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of multidrug resistance proteins P-glycoprotein, multidrug resistance protein 1, breast cancer resistance protein and lung resistance related protein in locally advanced bladder cancer treated with neoadjuvant chemotherapy: biological and clinical implications.
    Diestra JE; Condom E; Del Muro XG; Scheffer GL; Pérez J; Zurita AJ; Muñoz-Seguí J; Vigués F; Scheper RJ; Capellá G; Germà-Lluch JR; Izquierdo MA
    J Urol; 2003 Oct; 170(4 Pt 1):1383-7. PubMed ID: 14501774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. vPARP Adjusts MVP Expression in Drug-resistant Cell Lines in Conjunction with MDR Proteins.
    Wojtowicz K; Januchowski R; Nowicki M; Zabel M
    Anticancer Res; 2017 Jun; 37(6):3015-3023. PubMed ID: 28551640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular functions of vaults and their involvement in multidrug resistance.
    Steiner E; Holzmann K; Elbling L; Micksche M; Berger W
    Curr Drug Targets; 2006 Aug; 7(8):923-34. PubMed ID: 16918321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of the breast cancer resistance protein (BCRP) in relapsed or refractory acute myeloid leukemia (AML).
    van den Heuvel-Eibrink MM; Wiemer EA; Prins A; Meijerink JP; Vossebeld PJ; van der Holt B; Pieters R; Sonneveld P
    Leukemia; 2002 May; 16(5):833-9. PubMed ID: 11986944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response.
    Burger H; Foekens JA; Look MP; Meijer-van Gelder ME; Klijn JG; Wiemer EA; Stoter G; Nooter K
    Clin Cancer Res; 2003 Feb; 9(2):827-36. PubMed ID: 12576456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A very early induction of major vault protein accompanied by increased drug resistance in U-937 cells.
    Hu Y; Stephen AG; Cao J; Tanzer LR; Slapak CA; Harrison SD; Devanarayan V; Dantzig AH; Starling JJ; Rome LH; Moore RE
    Int J Cancer; 2002 Jan; 97(2):149-56. PubMed ID: 11774257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung resistance-related protein/major vault protein and vaults in multidrug-resistant cancer.
    Scheffer GL; Schroeijers AB; Izquierdo MA; Wiemer EA; Scheper RJ
    Curr Opin Oncol; 2000 Nov; 12(6):550-6. PubMed ID: 11085454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The formation of vault-tubes: a dynamic interaction between vaults and vault PARP.
    van Zon A; Mossink MH; Schoester M; Houtsmuller AB; Scheffer GL; Scheper RJ; Sonneveld P; Wiemer EA
    J Cell Sci; 2003 Nov; 116(Pt 21):4391-400. PubMed ID: 13130096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased susceptibility of vault poly(ADP-ribose) polymerase-deficient mice to carcinogen-induced tumorigenesis.
    Raval-Fernandes S; Kickhoefer VA; Kitchen C; Rome LH
    Cancer Res; 2005 Oct; 65(19):8846-52. PubMed ID: 16204055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidrug resistance genes in infant acute lymphoblastic leukemia: Ara-C is not a substrate for the breast cancer resistance protein.
    Stam RW; van den Heuvel-Eibrink MM; den Boer ML; Ebus ME; Janka-Schaub GE; Allen JD; Pieters R
    Leukemia; 2004 Jan; 18(1):78-83. PubMed ID: 14574327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of MVP and VPARP assembly into vault ribonucleoprotein complexes.
    Zheng CL; Sumizawa T; Che XF; Tsuyama S; Furukawa T; Haraguchi M; Gao H; Gotanda T; Jueng HC; Murata F; Akiyama S
    Biochem Biophys Res Commun; 2005 Jan; 326(1):100-7. PubMed ID: 15567158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MVP Expression Facilitates Tumor Cell Proliferation and Migration Supporting the Metastasis of Colorectal Cancer Cells.
    Pietras P; Leśniczak-Staszak M; Kasprzak A; Andrzejewska M; Jopek K; Sowiński M; Rucinski M; Lyons SM; Ivanov P; Szaflarski W
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34829999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug resistance features and S-phase fraction as possible determinants for drug response in a panel of human ovarian cancer xenografts.
    Kolfschoten GM; Hulscher TM; Pinedo HM; Boven E
    Br J Cancer; 2000 Oct; 83(7):921-7. PubMed ID: 10970695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of multidrug resistance 1 (MDR1), multidrug resistance-related protein 1 (MRP1), lung resistance protein (LRP), and breast cancer resistance protein (BCRP) genes and clinical outcome in childhood acute lymphoblastic leukemia.
    Kourti M; Vavatsi N; Gombakis N; Sidi V; Tzimagiorgis G; Papageorgiou T; Koliouskas D; Athanassiadou F
    Int J Hematol; 2007 Aug; 86(2):166-73. PubMed ID: 17875533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-time quantitative polymerase chain reaction for BCRP, MDR1, and MRP1 mRNA levels in lymphocytes and monocytes.
    Moon YJ; Zhang S; Morris ME
    Acta Haematol; 2007; 118(3):169-75. PubMed ID: 17911978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.